GWDN Stocks Mixed in July; Affy Soars, Myriad Sags

Affymetrix's shares increased nearly 50 percent during the month on the strength of its Q2 results, while Myriad and Celera each dropped more than 20 percent as they said their respective quarterly revenues would be lower than previously expected.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.